Swedish Orphan Biovitrum AB (SWOBY)
23.28
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Swedish Orphan Biovitrum EPS Diluted (Quarterly) : 0.2064 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2064 |
| December 31, 2025 | 0.2839 |
| September 30, 2025 | -0.4411 |
| June 30, 2025 | 0.0948 |
| March 31, 2025 | 0.1181 |
| December 31, 2024 | 0.1867 |
| September 30, 2024 | 0.2025 |
| June 30, 2024 | 0.0304 |
| March 31, 2024 | 0.1118 |
| December 31, 2023 | 0.1402 |
| September 30, 2023 | 0.0136 |
| June 30, 2023 | 0.0335 |
| March 31, 2023 | 0.1631 |
| December 31, 2022 | 0.2065 |
| September 30, 2022 | 0.0683 |
| June 30, 2022 | 0.042 |
| March 31, 2022 | 0.0933 |
| December 31, 2021 | 0.2252 |
| September 30, 2021 | 0.0881 |
| June 30, 2021 | 0.0514 |
| March 31, 2021 | 0.1324 |
| December 31, 2020 | 0.2796 |
| September 30, 2020 | 0.0503 |
| June 30, 2020 | 0.047 |
| March 31, 2020 | 0.1962 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.228 |
| September 30, 2019 | 0.0912 |
| June 30, 2019 | 0.0854 |
| March 31, 2019 | 0.1625 |
| December 31, 2018 | 0.1162 |
| September 30, 2018 | 0.1228 |
| June 30, 2018 | 0.1392 |
| March 31, 2018 | 0.1121 |
| December 31, 2017 | 0.0758 |
| September 30, 2017 | 0.071 |
| June 30, 2017 | 0.0502 |
| March 31, 2017 | 0.0402 |
| December 31, 2016 | 0.0143 |
| September 30, 2016 | 0.0279 |
| June 30, 2016 | 0.0663 |
| March 31, 2016 | 0.0635 |
| December 31, 2015 | -0.0017 |
| September 30, 2015 | 0.0011 |
| June 30, 2015 | 0.0017 |
| March 31, 2015 | 0.0229 |
| December 31, 2014 | -0.0045 |
| September 30, 2014 | 0.0137 |
| June 30, 2014 | 0.0072 |
| March 31, 2014 | -0.0916 |
| December 31, 2013 | -0.0037 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hansa Biopharma AB | -0.2111 |
| BioArctic AB | 0.2615 |
| Diamyd Medical AB | -0.05 |
| BONESUPPORT HOLDING AB | 0.0875 |
| BioInvent International AB | -0.1982 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 144.19M |
| Revenue (Quarterly) | 785.93M |
| Total Expenses (Quarterly) | 641.74M |
| Enterprise Value | 18.01B |
| Gross Profit Margin (Quarterly) | 66.20% |
| Profit Margin (Quarterly) | 18.35% |
| Earnings Yield | 0.62% |
| Operating Earnings Yield | 5.64% |
| Normalized Earnings Yield | 3.908 |